You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 269 No. 14, April 14, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Confronting Multidrug Resistance

A Role for Each of Us

Stuart B. Levy, MD

JAMA. 1993;269(14):1840-1842.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SCIENTIFIC journals, an Institute of Medicine study, newspapers, and magazines report the reappearance of "old" pathogens as major clinical problems worldwide.1-3 In particular, Mycobacterium tuberculosis and Plasmodium falciparum have been cited. In fact, this reemergence includes a diverse group of infectious organisms that have a common feature— multidrug resistance.

Soon after penicillin was introduced into clinical practice, physicians became keenly aware that the bacteria being attacked, namely the staphylococci, were not going to succumb easily to this antibiotic and, in retrospect, to many others. Their "resistance" was linked to a gene that coded for an enzyme, penicillinase, which destroyed penicillin. To complicate matters, the gene was not carried on the chromosome, as was expected, but instead, resided on a self-replicating extrachromosomal DNA unit—what we now call a plasmid. Plasmids are not novel elements limited to only certain bacteria. They are common components of the total genetic composition of most, . . . [Full Text PDF of this Article]


Author Affiliations

From the Center for Adaptation Genetics and Drug Resistance, Departments of Molecular Biology and Microbiology and of Medicine, Tufts University School of Medicine, and the New England Medical Center, Boston, Mass.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.